Chapter 50
Needs Analysis and Selection of Point-Of-Care Testing Analyzers
Albert Huisman PhD,
Albert Huisman PhD
University Medical Center Utrecht, Department of Clinical Chemistry and Haematology, Utrecht, The Netherlands
Search for more papers by this authorAlbert Huisman PhD,
Albert Huisman PhD
University Medical Center Utrecht, Department of Clinical Chemistry and Haematology, Utrecht, The Netherlands
Search for more papers by this authorBook Editor(s):Kandice Kottke-Marchant MD, PhD,
Bruce H. Davis MD,
Kandice Kottke-Marchant MD, PhD
Pathology & Laboratory Medicine Institute, Cleveland, OH, USA
Department of Pathology, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA
Hemostasis and Thrombosis, Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH, USA
Search for more papers by this authorFirst published: 10 April 2012
Summary
This chapter describes point-of-care (POC) testing, including recent guidelines, needs analysis, clinical and economic outcome, organization and quality management, and platform selection.
References
- CAP. Point-of-care testing Checklist (revision 10/31/2006) College of American Pathologists; 2006.
- Pearson J. Point-of-care-testing and Clinical Governance. Clin Chem Lab Med 2006; 44: 765–767.
- Price CP, St. John A, Hicks JM. Point-of-Care Testing: What, Why, When and Where? In: Price CP, St. John A, Hicks JM (eds.) Point-of-care Testing, 2nd edn. Washington DC: American Association for Clinical Chemistry Press; 2004; 3–9.
- Price CP. Point-of-care testing. BMJ 2001; 322: 1285–1288.
- Cramb R. Guidelines for Point-of-Care Testing. In: Price CP, St. John A, Hicks JM (eds.) Point-of-care Testing, 2nd edn. Washington DC: American Association for Clinical Chemistry Press; 2004; 155–161.
- Briggs C, Carter J, Lee SH et al. ICSH Guideline for worldwide point-of-care testing in haematology with special reference to the complete blood count. Int J Lab Hematol 2008; 30: 105–116.
- Nichols JH, Christenson RH, Clarke W et al. Executive summary. The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: evidence-based practice for point - of-care testing. Clin Chim Acta 2007; 379: 14–28.
- Briedigkeit L, M ü ller-Plathe O, Schlebusch H et al. Recommendations of the German Working Group on medical laboratory testing (AML) on the introduction and quality assurance of procedures for Point-of-Care Testing (POCT) in hospitals. Clin Chem Lab Med 1999; 37: 919–925.
- Jacobs E, Arbique JC, Dunka LJ et al. Point-of-Care In Vitro Diagnostic (IVD) Testing; Approved Guideline POCT4-A2, 2nd edn. Wayne, PA: Clinical and Laboratory Standards Institute; 2006.
- Briggs C, Guthrie D, Hyde K et al. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for point-of-care testing: haematology. Br J Haematol 2008; 142: 904–915.
- Joist JH, Ansell JE, Despotis GG et al. Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline H49-A. Wayne, PA: National Committee for Clinical Laboratory Standards; 2004.
- Zucker ML. The National Academy of Clinical Biochemistry Laboratory Medicine Practise Guidelines for Point-of-care Coagulation Testing. Point-of-care 2007; 6: 223–226.
- The Joint Working Group on Quality Assurance. Near to patient or point-of-care testing. Clin Lab Haematol 2000; 22: 185–188.
- Keffer JH. Health Economic Aspects of Point-of-Care Testing. In: Price CP, St. John A, Hicks JM (eds.) Point-of-care Testing, 2nd edn. Washington DC: American Association for Clinical Chemistry Press; 2004; 179–186.
- Gupta S, Bhattacharya A. Point-of-Care testing in Anaesthesiology and Intensive Care — an Overview. Indian J Anaesth 2004; 48: 278–286.
- Lin JC, Strauss RG, Kulhavy JC et al. Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics 2000; 106: E19.
- Madan A, Kumar R, Adams MM et al. Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants. J Perinatol 2005; 25: 21–25.
- Chant C, Wilson G, Friedrich JO. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit Care 2006; 10: R140.
- Kendall J, Reeves B, Clancy M. Point-of-care testing: randomized controlled trial of clinical outcome. BMJ 1998; 316: 1052–1057.
- Nichols JH, Kickler TS, Dyer KL et al. Clinical outcomes of point-of-care testing in the interventional radiology and invasive cardiology setting. Clin Chem 2000; 46: 543–550.
- Price CP. Medical and economic outcomes of point-of-care testing. Clin Chem Lab Med 2002; 40: 246–251.
- Collinson PO, John C, Lynch S et al. A prospective randomized controlled trial of point-of-care testing on the coronary care unit. Ann Clin Biochem 2004; 41: 397–404.
- Hsiao AL, Santucci KA, Dziura J et al. A Randomized Trial to Assess the Efficacy of Point-of-Care Testing in Decreasing Length of Stay in a Pediatric Emergency Department. Pediatr Emerg Care 2007; 23: 457–462.
- Rodger MA, Bredeson CN, Jones G et al. The bedside investigation of pulmonary embolism diagnosis study: a double-blind randomized controlled trial comparing combinations of 3 bedside tests vs ventilation-perfusion scan for the initial investigation of suspected pulmonary embolism. Arch Intern Med 2006; 166: 181–187.
- Avidan MS, Alcock EL, Da Fonseca J et al. Comparison of structured use of routine laboratory tests or near patient assessment with clinical judgment in the management of bleeding after cardiac surgery. Br J Anaesth 2004; 92: 178–186.
- Runyon MS, Beam DM, King MC et al. Comparison of the Simplify D-dimer assay performed at the bedside with a laboratory-based quantitative D-dimer assay for the diagnosis of pulmonary embolism in a low prevalence emergency department population. Emerg Med J 2008; 25: 70–75.
- Kearon C, Ginsberg JS, Douketis J et al. Canadian Pulmonary Embolism Diagnosis Study (CANPEDS) Group. An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med 2006; 144: 812–821.
- Gardiner C, Williams K, Mackie IJ et al. Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol 2005; 128: 242–247.
- Karon BS, McBane RD, Chaudhry R et al. Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers. Am J Clin Pathol 2008; 130: 88–92.
- Green TL, Mansoor A, Newcommon N et al. Reliability of point-of-care testing of INR in acute stroke. Can J Neurol Sci 2008; 35: 348–351.
- Hill J, Perreault S, Dorval M. Validity of CoaguChek S for home monitoring of anticoagulant therapy in pediatrics. Can J Cardiol 2007; 23: 47–50.
- Havrda DE, Hawk TL, Marvin CM. Accuracy and precision of the CoaguChek S versus laboratory INRs in a clinic. Ann Pharmacother 2002; 36: 769–775.
- Gehring H, Hornberger C, Dibbelt L et al. Accuracy of point-of-care-testing (POCT) for determining hemoglobin concentrations. Acta Anaesthesiol Scand 2002; 46: 980–986.
- Mu ñ oz M, Romero A, Gómez JF et al. Utility of point-of-care haemoglobin measurement in the HemoCue-B haemoglobin for the initial diagnosis of anaemia. Clin Lab Haematol 2005; 27: 99–104.
- van Solinge WW, Huisman A. Point-of-Care Testing in Hematology. In: Price CP, St. John A, Hicks JM (eds.) Point-of-care Testing, 2nd edn. Washington DC: American Association for Clinical Chemistry Press; 2004; 415–420.
- MDA. Management and Use of IVD Point-of-care Test Devices, MDA DB2002(03). London: Medical Devices Agency; 2002.
- Kost GJ. Preventing medical errors in point-of-care testing: security, validation, safeguards, and connectivity. Arch Pathol Lab Med 2001; 125: 1307–1315.
- Meier FA, Jones BA. Point-of-care testing error: sources and amplifiers, taxonomy, prevention strategies, and detection monitors. Arch Pathol Lab Med 2005; 129: 1262–1267.
- Krouwer JS, Tholen DW, Garber CC et al. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline EP09-A2, 2nd edn. Wayne, PA: Clinical and Laboratory Standards Institute; 2002.
